Acharya Rabinarayan, Naik Raghavendra, Rang Sourav, Jani Chitrangad A, Galib R
Department of Dravyaguna, ITRA, Gujarat Ayurved University, Jamnagar, Gujarat, India.
Peripheral Pharmacovigilance Centre for Ayurveda, Central Ayurveda Research Institute, Bengaluru, Karnataka, India.
J Family Med Prim Care. 2022 Feb;11(2):623-632. doi: 10.4103/jfmpc.jfmpc_1091_21. Epub 2022 Feb 16.
The aim of this study was to assess the knowledge, attitude, and practice towards pharmacovigilance for Ayurveda among the teachers and practitioners working in Ayurveda colleges of Gujarat State.
A survey questionnaire with 29 questions covering points like participants' knowledge, attitude and practice towards pharmacovigilance, adverse drug reaction reporting, and misleading advertisements related Ayurveda drugs was developed in Google form format. The study was carried out during December 2020 and January 2021. Question-wise analysis was made and their percentage value was calculated with the help of a Microsoft Excel spreadsheet in MS Office 2010. The result was presented using simple frequencies with percentages in appropriate tables.
Results from this study show that majority of the respondents were having a good knowledge regarding the concept of pharmacovigilance and ADRs in terms of their definitions and purposes. But, a complete knowledge regarding the structure of present national and international pharmacovigilance programme, reporting the ADR and its format were still lacking among majority of the participants. An encouraging attitude towards reporting of adverse drug reaction of ASU&H drugs and teaching of Pharmacovigilance for all the healthcare professionals by majority of the participants was observed. Further maximum participants opine a mandatory rule for reporting of ADR by Physicians, Pharmacist and Nursing staff. A major part of respondents (78.03%) opine that poor quality of drug, medication errors, prescription errors, dispensing errors are part of Pharmacovigilance under drug-related problems. The observed positive attitude is not being reflected in term of practice i.e., reporting of ADR related to Ayurveda drugs. One-third of the participants reported their experience about adverse drug reactions during their professional practice, out of which very few have reported ADRs. Difficulty in deciding or identifying the ADR and lack of time to report ADR is one of the major factor discouraging the participants from reporting ADRs. A large number of respondents were also not familiar with reporting misleading advertisements.
Findings of this study reflects a good knowledge of the participants about the concept of Pharmacovigilance but unfamiliarity about the programme. The positive attitude towards practice of Pharmacovigilance and ADR reporting can be converted to foster pharmacovigilance practice through series of awareness programmes.
本研究旨在评估古吉拉特邦阿育吠陀学院的教师和从业者对阿育吠陀药物警戒的知识、态度和实践情况。
在谷歌表单格式中设计了一份包含29个问题的调查问卷，内容涵盖参与者对药物警戒、药品不良反应报告以及与阿育吠陀药物相关的误导性广告的知识、态度和实践等方面。该研究于2020年12月至2021年1月期间开展。进行了逐题分析，并借助MS Office 2010中的Microsoft Excel电子表格计算其百分比值。结果以简单频率和百分比的形式呈现在适当的表格中。
本研究结果表明，大多数受访者在药物警戒和药品不良反应的定义及目的方面有良好的知识。但是，大多数参与者仍然缺乏关于当前国家和国际药物警戒计划的结构、报告药品不良反应及其格式的完整知识。观察到大多数参与者对报告阿育吠陀、 Siddha和顺势疗法（ASU&H）药物的药品不良反应以及为所有医疗保健专业人员开展药物警戒教学持鼓励态度。此外，大多数参与者认为医生、药剂师和护理人员有报告药品不良反应的强制性规定。大部分受访者（78.03%）认为药品质量差、用药错误、处方错误、调配错误是与药物相关问题中药物警戒的一部分。观察到的积极态度在实践中并未体现出来，即对与阿育吠陀药物相关的药品不良反应的报告。三分之一的参与者报告了他们在专业实践中有关药品不良反应的经历，其中很少有人报告过药品不良反应。难以确定或识别药品不良反应以及缺乏报告药品不良反应的时间是阻碍参与者报告药品不良反应的主要因素之一。大量受访者也不熟悉报告误导性广告。
本研究结果反映出参与者对药物警戒概念有良好的知识，但对该计划不熟悉。通过一系列提高认识的计划，可以将对药物警戒实践和药品不良反应报告的积极态度转化为促进药物警戒实践。
